Skip to main content
Top
Published in: Diabetologia 6/2016

Open Access 01-06-2016 | Review

The fetal glucose steal: an underappreciated phenomenon in diabetic pregnancy

Authors: Gernot Desoye, Christopher J. Nolan

Published in: Diabetologia | Issue 6/2016

Login to get access

Abstract

Adverse neonatal outcomes continue to be high for mothers with type 1 and type 2 diabetes, and are far from eliminated in mothers with gestational diabetes mellitus. This is often despite seemingly satisfactory glycaemic control in the latter half of pregnancy. Here we argue that this could be a consequence of the early establishment of fetal hyperinsulinaemia, a driver that exaggerates the fetal glucose steal. Essentially, fetal hyperinsulinaemia, through its effect on lowering fetal glycaemia, will increase the glucose concentration gradient across the placenta and consequently the glucose flux to the fetus. While the steepness of this gradient and glucose flux will be greatest at times when maternal hyperglycaemia and fetal hyperinsulinaemia coexist, fetal hyperinsulinaemia will favour a persistently high glucose flux even at times when maternal blood glucose is normal. The obvious implication is that glycaemic control needs to be optimised very early in pregnancy to prevent the establishment of fetal hyperinsulinaemia, further supporting the need for pre-pregnancy planning and early establishment of maternal glycaemic control. An exaggerated glucose steal by a hyperinsulinaemic fetus could also attenuate maternal glucose levels during an OGTT, providing an explanation for why some mothers with fetuses with all the characteristics of diabetic fetopathy have ‘normal’ glucose tolerance.
Literature
1.
go back to reference Colstrup M, Mathiesen ER, Damm P, Jensen DM, Ringholm L (2013) Pregnancy in women with type 1 diabetes: have the goals of st. Vincent declaration been met concerning foetal and neonatal complications? J Matern Fetal Neonatal Med 26:1682–1686CrossRefPubMed Colstrup M, Mathiesen ER, Damm P, Jensen DM, Ringholm L (2013) Pregnancy in women with type 1 diabetes: have the goals of st. Vincent declaration been met concerning foetal and neonatal complications? J Matern Fetal Neonatal Med 26:1682–1686CrossRefPubMed
2.
go back to reference Crowther CA, Hiller JE, Moss JR et al (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486CrossRefPubMed Crowther CA, Hiller JE, Moss JR et al (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486CrossRefPubMed
3.
4.
go back to reference Catalano PM, Thomas A, Huston-Presley L, Amini SB (2003) Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol 189:1698–1704CrossRefPubMed Catalano PM, Thomas A, Huston-Presley L, Amini SB (2003) Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol 189:1698–1704CrossRefPubMed
6.
go back to reference Nolan CJ, Proietto J (1994) The feto-placental glucose steal phenomenon is a major cause of maternal metabolic adaptation during late pregnancy in the rat. Diabetologia 37:976–984CrossRefPubMed Nolan CJ, Proietto J (1994) The feto-placental glucose steal phenomenon is a major cause of maternal metabolic adaptation during late pregnancy in the rat. Diabetologia 37:976–984CrossRefPubMed
7.
go back to reference Jodarski GD, Shanahan MF, Rankin JH (1985) Fetal insulin and placental 3-o-methyl glucose clearance in near-term sheep. J Dev Physiol 7:251–258PubMed Jodarski GD, Shanahan MF, Rankin JH (1985) Fetal insulin and placental 3-o-methyl glucose clearance in near-term sheep. J Dev Physiol 7:251–258PubMed
8.
go back to reference Molina RD, Carver TD, Hay WW Jr (1993) Ontogeny of insulin effect in fetal sheep. Pediatr Res 34:654–660CrossRefPubMed Molina RD, Carver TD, Hay WW Jr (1993) Ontogeny of insulin effect in fetal sheep. Pediatr Res 34:654–660CrossRefPubMed
9.
go back to reference Weiss PA, Scholz HS, Haas J, Tamussino KF (2001) Effect of fetal hyperinsulinism on oral glucose tolerance test results in patients with gestational diabetes mellitus. Am J Obstet Gynecol 184:470–475CrossRefPubMed Weiss PA, Scholz HS, Haas J, Tamussino KF (2001) Effect of fetal hyperinsulinism on oral glucose tolerance test results in patients with gestational diabetes mellitus. Am J Obstet Gynecol 184:470–475CrossRefPubMed
10.
go back to reference Marconi AM, Davoli E, Cetin I et al (1993) Impact of conceptus mass on glucose disposal rate in pregnant women. Am J Physiol 264:E514–E518PubMed Marconi AM, Davoli E, Cetin I et al (1993) Impact of conceptus mass on glucose disposal rate in pregnant women. Am J Physiol 264:E514–E518PubMed
11.
go back to reference Desoye G, van Poppel M (2015) The feto-placental dialogue and diabesity. Best Pract Res Clin Obstet Gynaecol 29:15–23CrossRefPubMed Desoye G, van Poppel M (2015) The feto-placental dialogue and diabesity. Best Pract Res Clin Obstet Gynaecol 29:15–23CrossRefPubMed
12.
go back to reference Pedersen J, Osler M (1961) Hyperglycemia as the cause of characteristic features of the foetus and newborn of diabetic mothers. Dan Med Bull 8:78–83PubMed Pedersen J, Osler M (1961) Hyperglycemia as the cause of characteristic features of the foetus and newborn of diabetic mothers. Dan Med Bull 8:78–83PubMed
13.
go back to reference Enzi G, Inelmen EM, Caretta F, Villani F, Zanardo V, DeBiasi F (1980) Development of adipose tissue in newborns of gestational-diabetic and insulin-dependent diabetic mothers. Diabetes 29:100–104CrossRefPubMed Enzi G, Inelmen EM, Caretta F, Villani F, Zanardo V, DeBiasi F (1980) Development of adipose tissue in newborns of gestational-diabetic and insulin-dependent diabetic mothers. Diabetes 29:100–104CrossRefPubMed
14.
go back to reference Milner RD, Ashworth MA, Barson AJ (1972) Insulin release from human foetal pancreas in response to glucose, leucine and arginine. J Endocrinol 52:497–505CrossRefPubMed Milner RD, Ashworth MA, Barson AJ (1972) Insulin release from human foetal pancreas in response to glucose, leucine and arginine. J Endocrinol 52:497–505CrossRefPubMed
15.
go back to reference Prentki M, Matschinsky FM, Madiraju SR (2013) Metabolic signaling in fuel-induced insulin secretion. Cell Metab 18:162–185CrossRefPubMed Prentki M, Matschinsky FM, Madiraju SR (2013) Metabolic signaling in fuel-induced insulin secretion. Cell Metab 18:162–185CrossRefPubMed
16.
go back to reference Molsted-Pedersen L (1972) Aspects of carbohydrate metabolism in newborn infants of diabetic mothers. I. Intravenous glucose tolerance tests (a) distribution and means of K values, and (b) correlation between K value and birth weight. Acta Endocrinol (Copenh) 69:174–188 Molsted-Pedersen L (1972) Aspects of carbohydrate metabolism in newborn infants of diabetic mothers. I. Intravenous glucose tolerance tests (a) distribution and means of K values, and (b) correlation between K value and birth weight. Acta Endocrinol (Copenh) 69:174–188
17.
go back to reference Piper K, Brickwood S, Turnpenny LW et al (2004) Beta cell differentiation during early human pancreas development. J Endocrinol 181:11–23CrossRefPubMed Piper K, Brickwood S, Turnpenny LW et al (2004) Beta cell differentiation during early human pancreas development. J Endocrinol 181:11–23CrossRefPubMed
18.
go back to reference Reiher H, Fuhrmann K, Noack S et al (1983) Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care 6:446–451CrossRefPubMed Reiher H, Fuhrmann K, Noack S et al (1983) Age-dependent insulin secretion of the endocrine pancreas in vitro from fetuses of diabetic and nondiabetic patients. Diabetes Care 6:446–451CrossRefPubMed
19.
go back to reference Weiss PA, Purstner P, Winter R, Lichtenegger W (1984) Insulin levels in amniotic fluid of normal and abnormal pregnancies. Obstet Gynecol 63:371–375PubMed Weiss PA, Purstner P, Winter R, Lichtenegger W (1984) Insulin levels in amniotic fluid of normal and abnormal pregnancies. Obstet Gynecol 63:371–375PubMed
20.
go back to reference Carpenter MW, Canick JA, Hogan JW, Shellum C, Somers M, Star JA (2001) Amniotic fluid insulin at 14-20 weeks’ gestation: association with later maternal glucose intolerance and birth macrosomia. Diabetes Care 24:1259–1263CrossRefPubMed Carpenter MW, Canick JA, Hogan JW, Shellum C, Somers M, Star JA (2001) Amniotic fluid insulin at 14-20 weeks’ gestation: association with later maternal glucose intolerance and birth macrosomia. Diabetes Care 24:1259–1263CrossRefPubMed
21.
go back to reference Desoye G, Hofmann HH, Weiss PA (1992) Insulin binding to trophoblast plasma membranes and placental glycogen content in well-controlled gestational diabetic women treated with diet or insulin, in well-controlled overt diabetic patients and in healthy control subjects. Diabetologia 35:45–55CrossRefPubMed Desoye G, Hofmann HH, Weiss PA (1992) Insulin binding to trophoblast plasma membranes and placental glycogen content in well-controlled gestational diabetic women treated with diet or insulin, in well-controlled overt diabetic patients and in healthy control subjects. Diabetologia 35:45–55CrossRefPubMed
22.
go back to reference Adam PA, Teramo K, Raiha N, Gitlin D, Schwartz R (1969) Human fetal insulin metabolism early in gestation. Response to acute elevation of the fetal glucose concentration and placental transfer of human insulin-I-131. Diabetes 18:409–416CrossRefPubMed Adam PA, Teramo K, Raiha N, Gitlin D, Schwartz R (1969) Human fetal insulin metabolism early in gestation. Response to acute elevation of the fetal glucose concentration and placental transfer of human insulin-I-131. Diabetes 18:409–416CrossRefPubMed
23.
go back to reference Tisi DK, Burns DH, Luskey GW, Koski KG (2011) Fetal exposure to altered amniotic fluid glucose, insulin, and insulin-like growth factor-binding protein 1 occurs before screening for gestational diabetes mellitus. Diabetes Care 34:139–144CrossRefPubMedPubMedCentral Tisi DK, Burns DH, Luskey GW, Koski KG (2011) Fetal exposure to altered amniotic fluid glucose, insulin, and insulin-like growth factor-binding protein 1 occurs before screening for gestational diabetes mellitus. Diabetes Care 34:139–144CrossRefPubMedPubMedCentral
24.
go back to reference Van Assche FA (1997) Symmetric and asymmetric fetal macrosomia in relation to long-term consequences. Am J Obstet Gynecol 177:1563–1564PubMed Van Assche FA (1997) Symmetric and asymmetric fetal macrosomia in relation to long-term consequences. Am J Obstet Gynecol 177:1563–1564PubMed
25.
go back to reference Van Assche FA, Holemans K, Aerts L (2001) Long-term consequences for offspring of diabetes during pregnancy. Br Med Bull 60:173–182CrossRefPubMed Van Assche FA, Holemans K, Aerts L (2001) Long-term consequences for offspring of diabetes during pregnancy. Br Med Bull 60:173–182CrossRefPubMed
26.
27.
go back to reference Poissonnet CM, Burdi AR, Bookstein FL (1983) Growth and development of human adipose tissue during early gestation. Early Hum Dev 8:1–11CrossRefPubMed Poissonnet CM, Burdi AR, Bookstein FL (1983) Growth and development of human adipose tissue during early gestation. Early Hum Dev 8:1–11CrossRefPubMed
28.
go back to reference The HAPO Study Cooperative Research Group (2009) Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 58:453–459CrossRefPubMedCentral The HAPO Study Cooperative Research Group (2009) Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes 58:453–459CrossRefPubMedCentral
29.
go back to reference Riskin-Mashiah S, Younes G, Damti A, Auslender R (2009) First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care 32:1639–1643CrossRefPubMedPubMedCentral Riskin-Mashiah S, Younes G, Damti A, Auslender R (2009) First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care 32:1639–1643CrossRefPubMedPubMedCentral
30.
31.
go back to reference Gold AE, Reilly R, Little J, Walker JD (1998) The effect of glycemic control in the pre-conception period and early pregnancy on birth weight in women with IDDM. Diabetes Care 21:535–538CrossRefPubMed Gold AE, Reilly R, Little J, Walker JD (1998) The effect of glycemic control in the pre-conception period and early pregnancy on birth weight in women with IDDM. Diabetes Care 21:535–538CrossRefPubMed
32.
go back to reference Raychaudhuri K, Maresh MJ (2000) Glycemic control throughout pregnancy and fetal growth in insulin-dependent diabetes. Obstet Gynecol 95:190–194PubMed Raychaudhuri K, Maresh MJ (2000) Glycemic control throughout pregnancy and fetal growth in insulin-dependent diabetes. Obstet Gynecol 95:190–194PubMed
33.
go back to reference Rey E, Attie C, Bonin A (1999) The effects of first-trimester diabetes control on the incidence of macrosomia. Am J Obstet Gynecol 181:202–206CrossRefPubMed Rey E, Attie C, Bonin A (1999) The effects of first-trimester diabetes control on the incidence of macrosomia. Am J Obstet Gynecol 181:202–206CrossRefPubMed
34.
go back to reference Wong SF, Lee-Tannock A, Amaraddio D, Chan FY, McIntyre HD (2006) Fetal growth patterns in fetuses of women with pregestational diabetes mellitus. Ultrasound Obstet Gynecol 28:934–938CrossRefPubMed Wong SF, Lee-Tannock A, Amaraddio D, Chan FY, McIntyre HD (2006) Fetal growth patterns in fetuses of women with pregestational diabetes mellitus. Ultrasound Obstet Gynecol 28:934–938CrossRefPubMed
35.
go back to reference Kerssen A, de Valk HW, Visser GH (2007) Increased second trimester maternal glucose levels are related to extremely large-for-gestational-age infants in women with type 1 diabetes. Diabetes Care 30:1069–1074CrossRefPubMed Kerssen A, de Valk HW, Visser GH (2007) Increased second trimester maternal glucose levels are related to extremely large-for-gestational-age infants in women with type 1 diabetes. Diabetes Care 30:1069–1074CrossRefPubMed
36.
go back to reference Gu L, Liu H, Gu X, Boots C, Moley KH, Wang Q (2015) Metabolic control of oocyte development: linking maternal nutrition and reproductive outcomes. Cell Mol Life Sci 72:251–271CrossRefPubMedPubMedCentral Gu L, Liu H, Gu X, Boots C, Moley KH, Wang Q (2015) Metabolic control of oocyte development: linking maternal nutrition and reproductive outcomes. Cell Mol Life Sci 72:251–271CrossRefPubMedPubMedCentral
37.
go back to reference Turner N, Robker RL (2015) Developmental programming of obesity and insulin resistance: does mitochondrial dysfunction in oocytes play a role? Mol Hum Reprod 21:23–30CrossRefPubMed Turner N, Robker RL (2015) Developmental programming of obesity and insulin resistance: does mitochondrial dysfunction in oocytes play a role? Mol Hum Reprod 21:23–30CrossRefPubMed
38.
go back to reference Damm P, Mersebach H, Rastam J et al (2014) Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA1c and spikes of high glucose values in the third trimester. J Matern Fetal Neonatal Med 27:149–154CrossRefPubMedPubMedCentral Damm P, Mersebach H, Rastam J et al (2014) Poor pregnancy outcome in women with type 1 diabetes is predicted by elevated HbA1c and spikes of high glucose values in the third trimester. J Matern Fetal Neonatal Med 27:149–154CrossRefPubMedPubMedCentral
39.
go back to reference Glinianaia SV, Tennant PW, Bilous RW, Rankin J, Bell R (2012) HbA1c and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study. Diabetologia 55:3193–3203CrossRefPubMed Glinianaia SV, Tennant PW, Bilous RW, Rankin J, Bell R (2012) HbA1c and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study. Diabetologia 55:3193–3203CrossRefPubMed
40.
go back to reference Weiss PA, Hofmann HM, Kainer F, Haas JG (1988) Fetal outcome in gestational diabetes with elevated amniotic fluid insulin levels. Dietary versus insulin treatment. Diabetes Res Clin Pract 5:1–7CrossRefPubMed Weiss PA, Hofmann HM, Kainer F, Haas JG (1988) Fetal outcome in gestational diabetes with elevated amniotic fluid insulin levels. Dietary versus insulin treatment. Diabetes Res Clin Pract 5:1–7CrossRefPubMed
41.
go back to reference Catalano PM, McIntyre HD, Cruickshank JK et al (2012) The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 35:780–786CrossRefPubMedPubMedCentral Catalano PM, McIntyre HD, Cruickshank JK et al (2012) The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care 35:780–786CrossRefPubMedPubMedCentral
42.
go back to reference Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S (1998) Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 19:268–270CrossRefPubMed Hattersley AT, Beards F, Ballantyne E, Appleton M, Harvey R, Ellard S (1998) Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 19:268–270CrossRefPubMed
43.
go back to reference Dancis J, Jansen V, Kayden HJ, Bjornson L, Levitz M (1974) Transfer across perfused human placenta. 3. Effect of chain length on transfer of free fatty acids. Pediatr Res 8:796–799CrossRefPubMed Dancis J, Jansen V, Kayden HJ, Bjornson L, Levitz M (1974) Transfer across perfused human placenta. 3. Effect of chain length on transfer of free fatty acids. Pediatr Res 8:796–799CrossRefPubMed
Metadata
Title
The fetal glucose steal: an underappreciated phenomenon in diabetic pregnancy
Authors
Gernot Desoye
Christopher J. Nolan
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 6/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-3931-6

Other articles of this Issue 6/2016

Diabetologia 6/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.